tirzepatide semaglutide head to head A head-to-head study found that patients on (Zepbound/Mounjaro) tirzepatide semaglutide head to head

Here, we present for the first time two cases, one with a systemic immediate hypersensitivity reaction and the other with a local immediate hypersensitivity reaction due to exenatide, who were both able to receive their drug with the same desensitization protocol

It notes PCPs are increasingly trained to evaluate, prescribe and monitor this therapy, and that straightforward prescribing often happens in primary care

Researchers in these studies deemed the treatment as safe and tolerable, with common side effects including vivid dreams, and gastrointestinal symptoms such as nausea, abdominal pain, constipation, and diarrhea

RNA-Seq bioinformatics analysis The raw sequencing data was quality checked using FastQC v